Correlation Between Dynavax Technologies and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Esperion Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Esperion Therapeutics.
Diversification Opportunities for Dynavax Technologies and Esperion Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dynavax and Esperion is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Esperion Therapeutics
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.43 times more return on investment than Esperion Therapeutics. However, Dynavax Technologies is 2.33 times less risky than Esperion Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 1,134 in Dynavax Technologies on September 13, 2024 and sell it today you would earn a total of 174.00 from holding Dynavax Technologies or generate 15.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Esperion Therapeutics
Performance |
| Timeline |
| Dynavax Technologies |
| Esperion Therapeutics |
Dynavax Technologies and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Esperion Therapeutics
The main advantage of trading using opposite Dynavax Technologies and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |